Ledger.Open graph →

SEC Form D · filed December 22, 2021

AZIYO BIOLOGICS, INC

Offering

$14.0M

Sold

$14.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SILVER SPRING, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Brigid A. Makes · Silver Spring, MDDirector Maybelle M. Jordan · Silver Spring, MDDirector W. M. Zuga · Silver Spring, MDDirector Jeffrey D. Hamet · Silver Spring, MDExec Matthew Ferguson · Silver Spring, MDExec Ronald D. Lloyd · Silver Spring, MDExec · Director Kevin R. Rakin · Silver Spring, MDDirector Mark Southworth · Alhambra, CADirector Matthew H. Roesch · Palo Alto, CAExec Mitchell M. London · Redmond, WAExec · Director Gregory Link · Grand Cayman, Cayman IslandsDirector Ralph Woodford · Grand Cayman, Cayman IslandsExec Jeff Aerni · CHICAGO, ILDirector Eng W. Kung · SALT LAKE CITY, UTDirector C. R. Mills. Ph.D · Silver Spring, MDDirector Nicole Walker · Ann Arbor, MIExec Eric W. Jacobsen · Lake Oswego, ORDirector Kokila Doshi · San Diego, CAExec · Director Andrew Dickson · Naples, FLDirector Florentine S. Catudan · Miami, FLExec Harpreet S. Sihota · Miami, FLDirector Suzanne Sevier · Centerville, OHDirector C. R. Mills. Ph.D · Silver Spring, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗